Effect of vitamin D replacement on immunological biomarkers in patients with multiple sclerosis.

Citation data:

Clinical immunology (Orlando, Fla.), ISSN: 1521-7035, Vol: 181, Page: 9-15

Publication Year:
2017
Usage 65
Abstract Views 54
Link-outs 11
Captures 14
Readers 14
Social Media 47
Shares, Likes & Comments 44
Tweets 3
Citations 1
Citation Indexes 1
PMID:
28536054
DOI:
10.1016/j.clim.2017.05.017
Author(s):
Mrad, May F; El Ayoubi, Nabil K; Esmerian, Maria O; Kazan, Jalal M; Khoury, Samia J
Publisher(s):
Elsevier BV
Tags:
Medicine; Immunology and Microbiology
Most Recent Tweet View All Tweets
article description
We aimed to investigate the immunologic effects of vitamin D replacement in RRMS patients. In a controlled single center study, patients deficient in 25-hydroxyvitamin D (serum level<25ng/ml) received 10,000IU/week cholecalciferol for 3months. Sufficient vitamin D patients (serum level>35ng/ml) were followed for the same period. Assessments were performed at baseline and at 3months. 25-hydroxyvitamin D levels increased significantly from baseline to month-3 in the deficient group after treatment and remained stable in the sufficient group. We observed a decreased interferon-γ (IFNγ) secretion by CD4 T cells in vitamin D deficient group but not in the sufficient group, and a negative correlation between baseline serum vitamin D and IFNγ production. There was no change in the frequency of T helper or regulatory T cell subsets in either group. Increasing serum levels of 25-hydroxyvitamin D are associated with decreased production of IFNγ by CD4 T cells.